Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

Dr Reddy's Laboratories

IIT Roorkee Recognised As Top Innovative Research Institution By Confederation Of Indian Industry
IIT Roorkee Recognised As Top Innovative Research Institution By Confederation Of Indian IndustryKaran KambleDec 20, 2021 11:32 AM +05:30 IST
DCGI Turns Down Dr Reddy's Application To Conduct Phase 3 Trials On Russia-Made Single Dose Sputnik Light Vaccine
DCGI Turns Down Dr Reddy's Application To Conduct Phase 3 Trials On Russia-Made Single Dose Sputnik Light VaccineSwarajya StaffJul 1, 2021 02:30 PM +05:30 IST
Dr Reddy’s Labs Launches Sputnik V Vaccine In India, Single Dose To Cost Rs 995.4, Price May Come Down When Local Supply Begins
Dr Reddy’s Labs Launches Sputnik V Vaccine In India, Single Dose To Cost Rs 995.4, Price May Come Down When Local Supply BeginsSwarajya StaffMay 14, 2021 01:06 PM +05:30 IST
Sputnik V Vaccine To Be Available For Use In India By Next Week
Sputnik V Vaccine To Be Available For Use In India By Next WeekSwarajya StaffMay 14, 2021 09:52 AM +05:30 IST
Dr Reddy’s Enters Into Voluntary Licensing Agreement To Manufacture Baricitinib Used For Covid-19 Treatment
Dr Reddy’s Enters Into Voluntary Licensing Agreement To Manufacture Baricitinib Used For Covid-19 TreatmentSwarajya StaffMay 12, 2021 01:16 PM +05:30 IST
DCGI Approves Emergency Use Of Drug Developed By DRDO Lab For Treatment Of Moderate To Severe COVID-19 Patients
DCGI Approves Emergency Use Of Drug Developed By DRDO Lab For Treatment Of Moderate To Severe COVID-19 PatientsSwarajya StaffMay 8, 2021 03:16 PM +05:30 IST
Russian COVID-19 Vaccine Sputnik V  Will Be Available In Few Weeks: Dr Reddy’s Lab CEO
Russian COVID-19 Vaccine Sputnik V Will Be Available In Few Weeks: Dr Reddy’s Lab CEOSwarajya StaffMay 2, 2021 11:09 AM +05:30 IST
First Batch Of 1,50,000 Sputnik V Covid Vaccine Doses To Arrive In India Today
First Batch Of 1,50,000 Sputnik V Covid Vaccine Doses To Arrive In India TodaySwarajya StaffMay 1, 2021 02:01 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype